The Action of Botulinum Toxin A on the Sternocleidomastoid Muscle: An Experimental Study on Rats
Open Access
- 8 February 2022
- journal article
- research article
- Published by Hindawi Limited in The Scientific World Journal
- Vol. 2022, 1-6
Abstract
In this study, we aim to investigate the effective dose of botulinum neurotoxin A that results in paralysis of the sternocleidomastoid muscle for a minimum duration of 28 days in Wistar rats. This research is the first in a series of studies to investigate the value of botulinum toxin A in the healing of clavicle fractures through the temporary paralysis of the sternocleidomastoid. A surgical incision was made under general anaesthesia, and botulinum neurotoxin A in respective doses of 4 and 6 international units (IU) or normal saline in equivalent volumes were injected directly into the exposed muscle. Electromyography was conducted on days 0, 7, and 28 following substance administration to determine the extent of muscle paralysis. Electromyography on day 0 showed no paralysis in either group. Animals injected with neurotoxin all exhibited paralysis on days 7 and 28 that was weaker in the group injected with the smaller dose of 4IU. One death occurred in the group injected with the higher dose (6IU), whereas in the control group, no paralysis was seen. Botulinum neurotoxin A in a dose of 6IU resulted in complete paralysis of the sternocleidomastoid in rats for a minimum of 28 days. A dose of 4IU resulted in less potent paralysis but was safer in our research. Botulinum neurotoxin is a substance utilised in cosmetics and therapeutics for many years, yet research shows that its use can be expanded to target a wider range of pathologies. In this series of studies, we aim to explore the neurotoxins applications on the treatment of clavicle fractures. To investigate this, we need to first establish the duration of its action on the sternocleidomastoid muscle.Keywords
This publication has 26 references indexed in Scilit:
- The Convergence of Medicine and Neurotoxins: A Focus on Botulinum Toxin Type A and Its Application in Aesthetic Medicine—A Global, Evidence-Based Botulinum Toxin Consensus Education InitiativeDermatologic Surgery, 2013
- Effects of botulinum toxin A on fracture healing in rats: an experimental studyJournal of Orthopaedic Science, 2012
- Transient muscle paralysis degrades bone via rapid osteoclastogenesisThe FASEB Journal, 2011
- Short‐term muscle atrophy caused by botulinum toxin‐A local injection impairs fracture healing in the rat femurJournal of Orthopaedic Research, 2011
- Locations of the Motor Endplate Band and Motoneurons Innervating the Sternomastoid Muscle in the RatThe Anatomical Record, 2010
- Botulinum Toxin-A Injections Into Neurogenic Overactive Bladder—To Include or Exclude the Trigone? A Prospective, Randomized, Controlled TrialJournal of Urology, 2010
- Immunohistochemical Expression of Muscarinic Receptors in the Urothelium and Suburothelium of Neurogenic and Idiopathic Overactive Human Bladders, and Changes With Botulinum Neurotoxin AdministrationJournal of Urology, 2010
- Botulinum ToxinAmerican Journal of Clinical Dermatology, 2010
- Influence of age and gender on dose and effectiveness of botulinum toxin for laryngeal dystoniaThe Laryngoscope, 2009
- Long-term botulinum toxin treatment of cervical dystonia – EMG changes in injected and noninjected musclesClinical Neurophysiology, 1999